SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is under pressure as traders react to the boards investigation into CEO Jensen Huangs admitted affair and allegations that the woman involved had ties to Chinese intelligence; the espionage claims remain unverified. The community is split between concerns about leadership and disclosure risks and views that the selloff is an overreaction and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is drawing attention ahead of its quarterly results after a sharp share-price decline, with traders debating whether the selloff signals weak results or is an opportunity to buy the dip. The Eli Lilly obesity-drug partnership is viewed as a growth opportunity, but some investors worry that branded medications could pressure margins; speculation about an earnings leak remains unverified.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly revenue beat and higher full-year outlook, driven by BRIUMVI growth, are the main focus; shares saw a sharp post-results dip and recovery, prompting debate over a sell the news reaction versus short-driven volatility. Traders are also watching for Phase 3 results on subcutaneous BRIUMVI as a next potential catalyst.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors HOPE-3 cardiac results receiving an American Heart Association research award has renewed attention to deramiocel ahead of the FDAs November 22 PDUFA decision for Duchenne muscular dystrophy. Traders are largely hopeful for approvalespecially on upper-limb function, which they distinguish from the advisory panels negative cardiac votewhile others stress that the outcome and any cardiac label remain uncertain.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps outperform, with traders describing a possible low-volume short squeeze and rotation into the Russell 2000. Bulls are chasing calls and citing hopes for easing inflation, while skeptics question the moves strength given reported weak flows and limited volume.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC findings on immune activation and viral clearance, alongside its positive Phase 3 prostate-cancer results, are drawing attention as the company prepares a BLA for CAN-2409. Bulls see the data as supportive of the regulatory package, while skeptics question filing and manufacturing execution and warn of a possible sell-the-news reaction.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is drawing support from Oppenheimers upgrade to Outperform on its AI and data-center outlook, alongside community discussion of Google Cloud using EPYC processors in its TPU infrastructure. Traders also see a possible rotation from Nvidia amid headlines about a board investigation into CEO Jensen Huang, while some caution that AMDs valuation and the sharp run-up leave room for volatility.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

A quarterly earnings shortfall and reduced full-year revenue guidance, tied largely to federal Dedrone drone deployments being delayed, have driven a sharp selloff. Traders debate whether the decline overreacts to a timing issue or reflects high valuation and weaker near-term growth, with some buying the dip and others expecting further downside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are surging ahead of its Q3 results, with traders speculating about short covering and an possible earnings leak, though neither is confirmed. Bulls hope for a turnaround and stronger guidance, while skeptics warn that slowing ad growth and past post-earnings declines could lead to a reversal.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is drawing attention as traders debate whether renewed scrutiny around Nvidia CEO Jensen Huang and alleged China-related chip diversions is weighing on the stock by association; some argue the concerns are speculative or unrelated to SMCI. The debate is sharpened by the stocks weak performance despite recent strong results and raised guidance, with bulls pointing to its valuation and bears citing governance, cash flow, and margin risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results

Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results Ridgetech, Inc. Reports Fiscal Year 2026 Financial Results PR Newswire HANGZHOU, China, July 31, 2026 HANGZHOU, China, July 31, 2026 /PRNewswire/ -- Ridgetech, Inc. (Nasdaq: RDGT) ("Ridgetech" or the "Company"), a wholesale distributor of...

Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association

Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association Ridgetech Strengthens Pharmaceutical Ecosystem Leadership with Vice-President Role in Zhejiang Biomedical Association PR Newswire HANGZHOU, China, July 24, 2026 HANGZHOU, China...

What's Going On With Ridgetech Stock Friday?

Ridgetech (RDGT) shares retreat following a massive 1-for-150 reverse split. Capital structure changes as the firm targets 30% B2B growth.read more...

RDGT Stock More Than Doubles Ahead Of Reverse Split As Turnaround Strategy Takes Center Stage

Equity

As part of the plan, each block of 150 shares will be consolidated into one share.


ZSPC, RDGT, JTAI Stocks Hit 52-Week Lows: What's Driving The Selloff?

Weak outlooks, reverse splits and penny-stock swings send shares tumbling, but retail sentiment diverges sharply.


Ridgetech To Implement 1-For-150 Reverse Share Split

(RTTNews) - Ridgetech, Inc. (RDGT), Friday announced its decision to implement a 1-for-150 reverse share split on its ordinary shares, effective April 7...

Ridgetech, Inc. Announces 1-for-150 Reverse Share Split

Ridgetech, Inc. Announces 1-for-150 Reverse Share Split Ridgetech, Inc. Announces 1-for-150 Reverse Share Split PR Newswire HANGZHOU, China, April 3, 2026 HANGZHOU, China, April 3, 2026 /PRNewswire...

What's Going On With Ridgetech Shares On Tuesday?

Ridgetech's 2026 strategy targets 300,000+ customers and deeper supplier partnerships.read more...

Ridgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value Creation

Ridgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value Creation Ridgetech Unveils 2026 Dual-Engine Growth Strategy to Drive Innovation and Value Creation PR Newswire...

Ridgetech, Inc. engages in retailing and distributing pharmaceutical and other healthcare products. It operates through the following business segments: Retail Drugstores, Online Pharmacy, Drug Wholesale, and Herb Farming. The Retail Drugstores segment refers to the selling of prescription and over-the-counter medicines, dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment is involved in selling of over-the-counter drugs, dietary supplements, medical devices, and sundry items through several third-party platforms. The Drug Wholesale segment includes supplying its retail drugstores with prescription and over-the-counter medicines, and selling its products to other drug vendors and hospitals. The Herb Farming cultivates selected herbs for sales to other drug vendors. The company was founded by Li Qi in September 2003 and is headquartered in Hangzhou, China.

Ridgetech Inc.

Extremely Bullish Sentiment

<ul class="summary-bullets"><li>Ridgetech’s reverse split takes effect Tuesday after market close.</li><li>As of April 2, the company had around 134.8 million shares, which will drop to about 898,906 post-split.</li><li>The company’s 2026 growth plan targets blending supply chain strength with digital expansion.</li></ul>Ridgetech, Inc. (RDGT) stock is drawing attention on Tuesday as its reverse stock split comes into effect at 5 p.m., after market close.The China-based healthcare products distributor is preparing to consolidate its share structure as part of a move to reshape its market profile while maintaining its listing on the Nasdaq Capital Market.<h2 class="st-heading-2">Reverse Split And Impact On Share Count&nbsp;</h2>Under the plan, every 150 existing shares will be combined into a single share, increasing the par value proportionally.&nbsp;The company currently has more than 134 million shares outstanding, and after the consolidation, that total is expected to shrink to fewer than one million shares. Ridgetech also stated it will not issue fractional shares; instead, any partial holdings will be rounded up to the nearest whole unit.<a href="https://stocktwits.com/symbol/RDGT">Ridgetech stock</a> traded over 109% by Tuesday mid-morning. On Stocktwits, retail sentiment around the stock flipped to ‘bullish’ from ‘neutral’ territory the previous day. Message volume shifted to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_04_07_110009_png_b5500999d4.webp" alt="RDGT’s Sentiment Meter and Message Volume as of 10:45 a.m. ET on Apr.7, 2026 | Source: Stocktwits" width="925" height="99"><figcaption>RDGT’s Sentiment Meter and Message Volume as of 10:45 a.m. ET on Apr.7, 2026 | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Strengthening Core Operations</h2>In March, Ridgetech outlined an ambitious 2026 roadmap to accelerate growth by integrating its physical distribution network with digital capabilities across China’s healthcare supply chain.The company said it will pursue a dual-engine strategy focused on integrating supply chain operations while expanding its online platform and franchise ecosystem to unlock new efficiencies and revenue streams.&nbsp;<blockquote>"In recent years, as demographic trends, policy orientation, and emerging technologies continue to reshape China's pharmaceutical and healthcare industry, the sector has entered a critical phase of profound transformation and accelerated restructuring.”-Frank Zhao, Interim CEO and CFO, Ridgetech</blockquote>RDGT stock has declined by over 98% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intel-repositions-as-foundry-powerhouse-with-space-x-and-tesla-s-terafab-deal-retail-cheers-the-move/cZJJuD5RIpA">Intel Repositions As Foundry Powerhouse With SpaceX And Tesla’s Terafab Deal: Retail Cheers The Move</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

As part of the plan, each block of 150 shares will be consolidated into one share.

Ridgetech, Inc.

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Current Price	$1.11
Prev Close	$1.00
Open	$1.11
Dividend Yield	0.00%
50-Day Moving Average	$0.8706
Beta	2.50
Avg. Volume	44,482.82
PE Ratio	-0.35

52-Week High	$760.50
52-Week Low	$0.67
Market Capitalization	$3.63M
EPS (Annual)	-$17.21
Price to Book	0.02
Revenue Per Employee	$2.07M

Feed

News

Sentiment

Fundamentals

Info

RDGT Fundamentals